This site uses its own and third-party cookies. Some of the cookies are necessary to navigate the site. To enable or limit cookies, or to obtain more information, click on Customize settings

Accept all cookies

Market Consensus

Sections of: Shareholders

Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).

FY 2022 (in €M):

Metric Min Max Average Contr.
Sales 2,348 2,429 2,403 117
Adjusted EBITDA 487 530 508 17
Adjusted EBITA  421 463 438 6
Cash Net Profit 223 290 266 13
Cash EPS 1,16 1,51 1,39 13
Net Working Capital 394 716 550 12
Net Debt 930 1,327 1,220 15

 

FY 2023 (in €M):

Metric Min Max Average Contr.
Sales 2,011 2,434 2,211 17
Adjusted EBITDA 385 527 443 17
Adjusted EBITA  314 401 363 6
Cash Net Profit 168 262 223 13
Cash EPS 0,87 1,36 1,16 13
Net Working Capital 366 671 462 12
Net Debt 717 1,181 1,047 15

 

* Data as of 20.02.2023

Notes:

  1. A total of 19 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have updated estimates post Fluidra's Q3 update (19.10.22).
  2. Firms contributing to the consensus are: Alantra, Banco Sabadell, Banco Santander, Bankinter, Berenberg, Bestinver, BoAML, Caixabank BPI, Citi, Exane BNP, Intermoney, JB Capital Markets, J.P.Morgan, Kepler, Mirabaud, Oddo and Renta 4.
  3. The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.